Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HART with mitomycin C + 5-FU versus cisplatin + 5-FU in locally advanced head and neck squamous cell carcinoma
DRKS00040575Phase 3Completed
- Sponsor
- German Working Group of Radiation Oncology
- Start
- Jan 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial in head and neck squamous cell carcinoma (HNSCC), oropharyngeal squamous cell carcinoma (OPSCC), squamous cell carcinoma of the hypopharynx and 4 more comparing HART + mitomycin C + 5-FU with HART + cisplatin + 5-FU (2 arms). Started Jan 2004; status: completed.
02
Drugs
mitomycin cfluorouracilcisplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)oropharyngeal squamous cell carcinoma (OPSCC)squamous cell carcinoma of the hypopharynxtonsil cancerbase of tongue cancer (BOTC)
Beyond the preview
Go deeper on DRKS00040575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00040575.